Neogen (NEOG) Competitors $9.02 -0.20 (-2.12%) As of 02:15 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends NEOG vs. MMSI, ICUI, HAE, XRAY, QDEL, STAA, CERS, OSUR, ANIK, and UTMDShould you be buying Neogen stock or one of its competitors? The main competitors of Neogen include Merit Medical Systems (MMSI), ICU Medical (ICUI), Haemonetics (HAE), DENTSPLY SIRONA (XRAY), QuidelOrtho (QDEL), STAAR Surgical (STAA), Cerus (CERS), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), and Utah Medical Products (UTMD). These companies are all part of the "health care supplies" industry. Neogen vs. Merit Medical Systems ICU Medical Haemonetics DENTSPLY SIRONA QuidelOrtho STAAR Surgical Cerus OraSure Technologies Anika Therapeutics Utah Medical Products Neogen (NASDAQ:NEOG) and Merit Medical Systems (NASDAQ:MMSI) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, community ranking, valuation, dividends, institutional ownership, risk, earnings, analyst recommendations and media sentiment. Is NEOG or MMSI more profitable? Merit Medical Systems has a net margin of 9.05% compared to Neogen's net margin of -52.12%. Merit Medical Systems' return on equity of 15.61% beat Neogen's return on equity.Company Net Margins Return on Equity Return on Assets Neogen-52.12% 2.89% 1.98% Merit Medical Systems 9.05%15.61%8.38% Do analysts prefer NEOG or MMSI? Neogen currently has a consensus price target of $14.00, suggesting a potential upside of 52.01%. Merit Medical Systems has a consensus price target of $110.78, suggesting a potential upside of 9.18%. Given Neogen's higher possible upside, analysts clearly believe Neogen is more favorable than Merit Medical Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Neogen 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Merit Medical Systems 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has stronger valuation & earnings, NEOG or MMSI? Merit Medical Systems has higher revenue and earnings than Neogen. Neogen is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeogen$913.83M2.19-$9.42M-$2.19-4.21Merit Medical Systems$1.36B4.40$94.41M$2.0349.98 Does the MarketBeat Community favor NEOG or MMSI? Merit Medical Systems received 115 more outperform votes than Neogen when rated by MarketBeat users. Likewise, 69.91% of users gave Merit Medical Systems an outperform vote while only 56.58% of users gave Neogen an outperform vote. CompanyUnderperformOutperformNeogenOutperform Votes33156.58% Underperform Votes25443.42% Merit Medical SystemsOutperform Votes44669.91% Underperform Votes19230.09% Does the media refer more to NEOG or MMSI? In the previous week, Merit Medical Systems had 6 more articles in the media than Neogen. MarketBeat recorded 9 mentions for Merit Medical Systems and 3 mentions for Neogen. Merit Medical Systems' average media sentiment score of 1.65 beat Neogen's score of 0.56 indicating that Merit Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Neogen 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Merit Medical Systems 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do insiders and institutionals hold more shares of NEOG or MMSI? 96.7% of Neogen shares are held by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are held by institutional investors. 1.1% of Neogen shares are held by insiders. Comparatively, 3.7% of Merit Medical Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more volatility & risk, NEOG or MMSI? Neogen has a beta of 1.27, indicating that its share price is 27% more volatile than the S&P 500. Comparatively, Merit Medical Systems has a beta of 0.91, indicating that its share price is 9% less volatile than the S&P 500. SummaryMerit Medical Systems beats Neogen on 17 of the 19 factors compared between the two stocks. Remove Ads Get Neogen News Delivered to You Automatically Sign up to receive the latest news and ratings for NEOG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NEOG vs. The Competition Export to ExcelMetricNeogenDiagnostic substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.00B$2.51B$5.73B$8.11BDividend YieldN/A0.72%4.41%4.08%P/E Ratio-4.215.6724.5019.28Price / Sales2.1954.44400.0989.77Price / Cash9.8015.7538.1134.64Price / Book0.633.146.914.38Net Income-$9.42M-$65.73M$3.18B$247.04M7 Day Performance-0.11%1.60%2.29%3.44%1 Month Performance-8.27%-11.81%0.72%-7.80%1 Year Performance-40.96%-23.20%14.02%4.07% Neogen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NEOGNeogen3.1373 of 5 stars$9.02-2.1%$14.00+55.3%-39.0%$1.96B$913.83M-4.122,110MMSIMerit Medical Systems3.7365 of 5 stars$100.68+1.8%$110.78+10.0%+38.8%$5.92B$1.36B49.356,950Analyst RevisionPositive NewsICUIICU Medical4.4302 of 5 stars$149.11+3.9%$168.67+13.1%+52.8%$3.66B$2.38B-32.6314,000Analyst UpgradePositive NewsHAEHaemonetics4.6216 of 5 stars$64.84-1.0%$101.67+56.8%-15.7%$3.26B$1.37B25.533,657Analyst ForecastAnalyst RevisionNews CoveragePositive NewsXRAYDENTSPLY SIRONA4.9154 of 5 stars$15.59+0.2%$23.33+49.7%-52.7%$3.10B$3.79B-7.5315,000QDELQuidelOrtho4.4442 of 5 stars$36.23+0.3%$51.20+41.3%-28.1%$2.44B$2.78B-1.207,100News CoveragePositive NewsSTAASTAAR Surgical4.2544 of 5 stars$17.65+3.5%$26.86+52.2%-52.7%$870.34M$313.90M-43.041,115Analyst ForecastCERSCerus2.3724 of 5 stars$1.45-0.3%$4.00+176.8%-25.0%$268.47M$180.27M-13.14290Insider TradeOSUROraSure Technologies4.3504 of 5 stars$3.59+2.1%$5.50+53.4%-47.8%$268.16M$185.83M23.90840ANIKAnika Therapeutics3.8311 of 5 stars$16.17+1.6%$22.00+36.1%-37.1%$236.75M$119.91M-2.43300Analyst RevisionUTMDUtah Medical Products3.5119 of 5 stars$58.05+1.3%N/A-16.3%$196.91M$40.90M14.70180 Remove Ads Related Companies and Tools Related Companies MMSI Competitors ICUI Competitors HAE Competitors XRAY Competitors QDEL Competitors STAA Competitors CERS Competitors OSUR Competitors ANIK Competitors UTMD Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NEOG) was last updated on 3/20/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredYour Wealth is Under AttackHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredMusk’s real agenda in D.C. Companies connected to Elon’s new map of America are making major climbs in price. And on May 30, the next wav...Porter & Company | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neogen Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
